Written by John Kelly, CEO at Atomo Diagnostics
Since its formation in 2010, Atomo has been making waves in the diagnostics technology space with award-winning products. The company is also recognised by key global health partners for supporting early diagnosis of HIV, as well as its commitment to simplicity in device design.
Our mission has always been to provide the market with products that meet the needs of users, and to do that we’ve been working closely with researchers, health workers and end users around the world. As a result, we understand the challenges our products need to overcome, and so far Atomo has been successful in winning the respect of frontline healthcare providers as well as publich health organisations. With the support of Atomo’s investors and technology partners, the company’s future projects and new product developments are all designed to build on this success.
So why launch a blog now? It’s a really exciting time for the company following the announcement last week that Atomo has received the A$3.6 million grant from the Bill & Melinda Gates Foundation to develop a next-generation HIV self-test.
Atomo’s is a great story – and I’m as passionate about writing the next chapter as I am about sharing the work Atomo has done so far. The aim of this blog is to do just that, and I hope you enjoy reading my posts…